Showing results (181-190 of 372) with videos related to
Sort By:
Pageof 38
BMC Family Practice|June 3, 2014
Safety relevant knowledge of orally anticoagulated patients without self-monitoring: a baseline survey in primary careJean-François Chenot, Thanh Duc Hua, Manar Abu Abed, et al.BMC Complementary and Alternative Medicine|July 5, 2018
Reducing antibiotic use for uncomplicated urinary tract infection in general practice by treatment with uva-ursi (REGATTA) - a double-blind, randomized, controlled comparative effectiveness trialKambiz Afshar, Nina Fleischmann, Guido Schmiemann, et al.Journal of Neurology|January 23, 2022
Disease-modifying treatments for multiple sclerosis have not affected the incidence of neoplasms in clinical trials over 3 decades: a meta-analysis with meta-regressionDimitrios Papadopoulos, Panagiotis Gklinos, Giorgos Psarros, et al.Canadian Journal of Public Health = Revue Canadienne De Sante Publique|September 15, 2017
Redirecting public oral health fluoride varnish intervention to low socio-economic status children in AlbertaCynthia Huber, Sylvia Baran, Cindi de Graaff, et al.BMC Musculoskeletal Disorders|March 1, 2011
Study protocol: improving patient choice in treating low back pain (IMPACT-LBP): a randomised controlled trial of a decision support package for use in physical therapyShilpa Patel, Sally Brown, Tim Friede, et al.The American Journal of Cardiology|May 19, 2016
Prediction of Appropriate Shocks Using 24-Hour Holter Variables and T-Wave Alternans After First Implantable Cardioverter-Defibrillator Implantation in Patients With Ischemic or Nonischemic CardiomyopathyJoachim Seegers, Leonard Bergau, Pascal Muñoz Expósito, et al.Statistics in Medicine|November 28, 2019
Adaptive trial designs in diagnostic accuracy researchAntonia Zapf, Maria Stark, Oke Gerke, et al.Multiple Sclerosis and Related Disorders|February 21, 2022
Managing neuropsychological impairment in multiple sclerosis - Controlled study on a standardized metacognitive intervention (MaTiMS)Jana Pöttgen, Tim Friede, Stephanie Lau, et al.Systematic Reviews|July 1, 2022
Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)-a systematic review protocolThomas Lehnert, Christian Röver, Sascha Köpke, et al.Statistics in Biopharmaceutical Research|June 30, 2021
Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?Cornelia Ursula Kunz, Silke Jörgens, Frank Bretz, et al.Pageof 38